Literature DB >> 21927805

Is depression an inflammatory disorder?

Charles L Raison1, Andrew H Miller.   

Abstract

Studies consistently report that groups of individuals with major depressive disorder (MDD) demonstrate increased levels of a variety of peripheral inflammatory biomarkers when compared with groups of nondepressed individuals. These findings are often interpreted as meaning that MDD, even in medically healthy individuals, may be an inflammatory condition. In this article, we examine evidence for and against this idea by looking more closely into what the actual patterns of inflammatory findings indicate in terms of the relationship between MDD and the immune system. Data are presented in support of the idea that inflammation only contributes to depression in a subset of patients versus the possibility that the depressogenic effect of inflammatory activation is more widespread and varies depending on the degree of vulnerability any given individual evinces in interconnected physiologic systems known to be implicated in the etiology of MDD. Finally, the treatment implications of these various possibilities are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21927805      PMCID: PMC3285451          DOI: 10.1007/s11920-011-0232-0

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  89 in total

1.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

2.  Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

Authors:  Lucile Capuron; Jane F Gumnick; Dominique L Musselman; David H Lawson; Andrea Reemsnyder; Charles B Nemeroff; Andrew H Miller
Journal:  Neuropsychopharmacology       Date:  2002-05       Impact factor: 7.853

3.  Hippocampal volume and depression: a meta-analysis of MRI studies.

Authors:  Poul Videbech; Barbara Ravnkilde
Journal:  Am J Psychiatry       Date:  2004-11       Impact factor: 18.112

4.  Pathways linking depression, adiposity, and inflammatory markers in healthy young adults.

Authors:  Gregory E Miller; Kenneth E Freedland; Robert M Carney; Cinnamon A Stetler; William A Banks
Journal:  Brain Behav Immun       Date:  2003-08       Impact factor: 7.217

5.  Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.

Authors:  Lucile Capuron; Charles L Raison; Dominique L Musselman; David H Lawson; Charles B Nemeroff; Andrew H Miller
Journal:  Am J Psychiatry       Date:  2003-07       Impact factor: 18.112

6.  Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment.

Authors:  Lucile Capuron; Gabriele Neurauter; Dominique L Musselman; David H Lawson; Charles B Nemeroff; Dietmar Fuchs; Andrew H Miller
Journal:  Biol Psychiatry       Date:  2003-11-01       Impact factor: 13.382

Review 7.  When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders.

Authors:  Charles L Raison; Andrew H Miller
Journal:  Am J Psychiatry       Date:  2003-09       Impact factor: 18.112

8.  Association between depression and elevated C-reactive protein.

Authors:  Marion Danner; Stanislav V Kasl; Jerome L Abramson; Viola Vaccarino
Journal:  Psychosom Med       Date:  2003 May-Jun       Impact factor: 4.312

9.  Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.

Authors:  L Capuron; A Ravaud; P J Neveu; A H Miller; M Maes; R Dantzer
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

10.  Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study.

Authors:  Demosthenes B Panagiotakos; Christos Pitsavos; Christina Chrysohoou; Efi Tsetsekou; Charalambos Papageorgiou; George Christodoulou; Christodoulos Stefanadis
Journal:  Eur Heart J       Date:  2004-03       Impact factor: 29.983

View more
  177 in total

Review 1.  Inflammation: depression fans the flames and feasts on the heat.

Authors:  Janice K Kiecolt-Glaser; Heather M Derry; Christopher P Fagundes
Journal:  Am J Psychiatry       Date:  2015-09-11       Impact factor: 18.112

2.  Longitudinal association of inflammation with depressive symptoms: A 7-year cross-lagged twin difference study.

Authors:  Minxuan Huang; Shaoyong Su; Jack Goldberg; Andrew H Miller; Oleksiy M Levantsevych; Lucy Shallenberger; Pratik Pimple; Bradley Pearce; J Douglas Bremner; Viola Vaccarino
Journal:  Brain Behav Immun       Date:  2018-10-27       Impact factor: 7.217

Review 3.  Enduring influence of pubertal stressors on behavioral response to hormones in female mice.

Authors:  Jeffrey D Blaustein; Nafissa Ismail
Journal:  Horm Behav       Date:  2013-07       Impact factor: 3.587

4.  Circulating versus lipopolysaccharide-induced inflammatory markers as correlates of subthreshold depressive symptoms in older adults.

Authors:  S Melanie Lee; Silena Te; Elizabeth C Breen; Richard Olmstead; Michael R Irwin; Joshua H Cho
Journal:  World J Biol Psychiatry       Date:  2019-10-09       Impact factor: 4.132

5.  Additive contributions of childhood adversity and recent stressors to inflammation at midlife: Findings from the MIDUS study.

Authors:  Camelia E Hostinar; Margie E Lachman; Daniel K Mroczek; Teresa E Seeman; Gregory E Miller
Journal:  Dev Psychol       Date:  2015-09-21

6.  Inflammatory markers as predictors of depression and anxiety in adolescents: Statistical model building with component-wise gradient boosting.

Authors:  Consuelo Walss-Bass; Robert Suchting; Rene L Olvera; Douglas E Williamson
Journal:  J Affect Disord       Date:  2018-03-12       Impact factor: 4.839

Review 7.  Immune-neural connections: how the immune system's response to infectious agents influences behavior.

Authors:  Robert H McCusker; Keith W Kelley
Journal:  J Exp Biol       Date:  2013-01-01       Impact factor: 3.312

8.  Evaluation of periodontitis in hospital outpatients with major depressive disorder.

Authors:  A C O Solis; A H Marques; C M Pannuti; R F M Lotufo; F Lotufo-Neto
Journal:  J Periodontal Res       Date:  2013-04-16       Impact factor: 4.419

9.  An Association Between the Inflammatory Biomarker GlycA and Depressive Symptom Severity.

Authors:  Samara Huckvale; Stephanie Reyes; Alexandra Kulikova; Anand Rohatgi; Kayla A Riggs; E Sherwood Brown
Journal:  J Clin Psychiatry       Date:  2020-11-17       Impact factor: 4.384

10.  Antidepressant-like effect of celecoxib piroxicam in rat models of depression.

Authors:  Ronise M Santiago; Janaína Barbiero; Bruno J Martynhak; Suelen L Boschen; Luisa M da Silva; Maria F P Werner; Claudio Da Cunha; Roberto Andreatini; Marcelo M S Lima; Maria A B F Vital
Journal:  J Neural Transm (Vienna)       Date:  2014-01-24       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.